Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6212493 | 1.00 | ADORA3 (0.88) | ADORA3ADORA1 | |
| SCHEMBL6217410 | 0.95 | ADORA3 (0.91) | ADORA3ADORA1 | |
| SCHEMBL6212503 | 0.93 | ADORA3 (1.00) | ADORA3ADORA1 | |
| SCHEMBL6215549 | 0.93 | ADORA3 (0.89) | ADORA3ADORA1 | |
| SCHEMBL6702850 | 0.92 | ADORA3 (0.85) | ADORA3ADORA1 | |
| SCHEMBL6214457 | 0.92 | ADORA3 (0.92) | ADORA3ADORA1 | |
| SCHEMBL6214545 | 0.90 | ADORA3 (0.86) | ADORA3ADORA1 | |
| SCHEMBL6216378 | 0.90 | ADORA3 (0.86) | ADORA3ADORA1 | |
| SCHEMBL6213534 | 0.90 | ADORA3 (0.86) | ADORA3ADORA1 | |
| SCHEMBL6211694 | 0.89 | ADORA3 (0.86) | ADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040198693-A1 | Compounds for the treatment of ischemia | DENINNO MICHAEL P (US) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198693-A1 | Compounds for the treatment of ischemia | TNNI3, ADRB3, FABP3 | ADORA3 26/4885ADORA1 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.